drospirenone and ethinyl estradiol tablets
GPTKB entity
Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
combination drug
|
| gptkbp:activeIngredient |
gptkb:drospirenone
gptkb:ethinyl_estradiol |
| gptkbp:approvedBy |
gptkb:FDA
2001 |
| gptkbp:ATCCode |
G03AA12
|
| gptkbp:contraindication |
gptkb:liver_disease
history of thromboembolic disorders renal impairment adrenal insufficiency |
| gptkbp:drugClass |
oral contraceptive
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
drospirenone and ethinyl estradiol tablets
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedAs |
gptkb:Yaz
gptkb:Yasmin gptkb:Ocella |
| gptkbp:mechanismOfAction |
alters cervical mucus
suppresses ovulation alters endometrial lining |
| gptkbp:pregnancyCategory |
X
|
| gptkbp:regulates |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness increased risk of blood clots |
| gptkbp:usedFor |
treatment of acne
treatment of premenstrual dysphoric disorder contraception |
| gptkbp:bfsParent |
gptkb:Loryna
|
| gptkbp:bfsLayer |
7
|